The old days of hepatitis C treatments are behind us. Up until
1 March 2016 hepatitis C treatment relied upon a drug that was poorly regarded by many patients and doctors, had a significant side-effect profile, was taken for 24-48 weeks with sub-optimal chance of cure. New direct-acting antiviral medicines for hepatitis C are an incredible advance in technology and patient experience.
Some people report complementary medicines help to alleviate symptoms of their chronic hepatitis C; however, some complementary medicines can be harmful to the liver. Therefore, the best outcomes are achieved through collaboration between the person with
hepatitis C, their GP or liver specialist, and their complementary medicine practitioner.